83 results on '"Ridolfi R."'
Search Results
2. Structural control of gas migration pathways in the hydrocarbon-rich Val d’Agri basin (Southern Apennines, Italy)
3. The fragmentation trigger of the FOOT experiment
4. Elemental fragmentation cross sections for a 16O beam of 400 MeV/u kinetic energy interacting with a graphite target using the FOOT ΔE-TOF detectors
5. The Microstrip Silicon Detector (MSD) data acquisition system architecture for the FOOT experiment
6. Enhancing the understanding of fragmentation processes in hadrontherapy and radioprotection in space with the FOOT experiment
7. Charge identification of nuclear fragments with the FOOT Time-Of-Flight system
8. Emergy
9. Measurement of 12C Fragmentation Cross Sections on C, O, and H in the Energy Range of Interest for Particle Therapy Applications
10. Ion charge separation with new generation of nuclear emulsion films
11. Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study
12. Circulating microRNAs (miRNAs): Biomarkers for Lung Cancer
13. Style modification in breast and Colorectal Cancer Patients: results of a pilot study Long-Survivors
14. Cancer Registries Underestimate both the Type of Disease and also Number of Cases due to Pollution
15. No city for children
16. Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
17. Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma
18. Safety and Efficacy of Ipilimumab 10 Mg/Kg Among Patients with Advanced Melanoma from Italy Enrolled in a European Compassionate Use Program
19. Sequential Combination of Low Dose Chemo-Modulating Temozolomide with Fotemustine in Metastatic Melanoma (MM). A Phase II Study
20. Intelligent Transport Systems (ITS) applications on dangerous good transport on road in Italy
21. Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study
22. 9305 ORAL A Phase II Study Combining Ipilimumab and Fotemustine in Patients With Metastatic Melanoma – the NIBIT-M1 Trial
23. 6106 POSTER Immune-boost Treatment With Gemcitabine, Oxaliplatin, Levofolinate, 5-flurouracil, Granulocyte/macrophage Colony-stimulating-factor (GM-CSF) and Aldesleukine Enhances Progression-free and Overall-survival Over FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients – Early Results From the GOLFIG-2 Phase III Trial
24. Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations.
25. A phase II study combining ipilimumab and fotemustine in patients with metastatic melanoma: The NIBIT-M1 trial.
26. Use of microRNA signature to predict patient sensitivity to dendritic cell vaccination in metastatic melanoma.
27. Low-dose temozolomide modulation of peripheral blood regulatory T cells before dendritic cell-based vaccination in metastatic melanoma: Phase I/II study.
28. Improved survival for stage III/IV melanoma from an unknown primary site (MUP): An Italian multicentric study.
29. Safety and efficacy of Scrambler therapy for cancer pain.
30. 9317 Ipilimumab re-induction after progression in patients with advanced melanoma enrolled in Phase II clinical trials
31. 1064 Invasive breast tumour cells induce up regulation of tumour endothelial marker 8 (TEM8) in monocytes
32. 9304 Identification of tumor biopsy markers as potential predictors of ipilimumab clinical activity in patients with advanced melanoma
33. 7107 A randomized, prospective, Phase 2 study, with Sorafenib (So) and Interleukin-2 (IL-2) versus So alone as first line treatment in advanced Renal Cell Cancer (RCC): ROSORC Trial
34. 9328 The Italian experience on the feasibility and safety of ipilimumab therapy in pretreated metastatic melanoma patients
35. 9315 Ipilimumab in pretreated metastatic uveal melanoma patients: safety and clinical efficacy
36. A multi-criteria assessment of six energy conversion processes for H2 production
37. Dendritic cell vaccination in melanoma patients: Update and subgroup analysis of clinical response to post-vaccine treatment
38. Italian multicentric trial comparing chemotherapy with or without low-dose interleukin-2 (IL-2) in advanced non-small cell lung cancer: Results from a phase III randomized study
39. The solar transformity of petroleum fuels
40. Specific emergy of cement and concrete: An energy-based appraisal of building materials and their transport
41. Temozolomide (TMZ) as prophylaxis for melanoma brain metastases (BrM): Results from a phase III, multicenter study
42. Safety and efficacy of ipilimumab with or without prophylactic budesonide in treatment-naive and previously treated patients with advanced melanoma
43. Effect of prior treatment status on the efficacy and safety of ipilimumab monotherapy in treatment-naive and previously treated patients with advanced melanoma
44. Dendritic cell (DC) antitumor vaccine: TEM8 expression in matured DC identifies clinical responders
45. The application of environmental certification to the Province of Siena
46. The greenhouse gas balance of the Province of Siena
47. Emergence of novelties: a thermodynamic approach to ecosystems
48. Decreasing greenhouse effect in agriculture using biodiesel — when green may be enough
49. Emergy analysis for the environmental sustainability of an inshore fish farming system
50. Time series analysis of the ISEW at the local (regional) level: method and intent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.